相关实验视频
Updated: Jul 4, 2025

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.1K
孕期肥胖:需要考虑什么? 如何交付?如何交付?
1Department of Obstetrics and Gynaecology, Erlangen University Hospital, Universitätsstr. 21-23, 91054, Erlangen, Germany. sven.kehl@gmail.com.
Archives of gynecology and obstetrics
|February 7, 2024
概括
在怀孕期间管理肥胖症需要专门的护理劳动诱导和分娩. 这包括在剖腹产期间计划潜在的并发症,并对产后监测保持警,以确保最佳的母亲和婴儿结果.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 公共卫生 公共卫生
背景情况:
- 怀孕期间的肥胖是一个越来越令人担忧的问题,增加了母亲和孩子的风险.
- 在肥胖的孕妇中,劳动和分娩的最佳管理策略尚未明确.
- 现有的指导方针缺乏针对接受剖腹产的肥胖患者的具体建议.
研究的目的:
- 审查肥胖孕妇管理劳动和分娩的挑战和考虑.
- 突出这一群体中剖腹产时需要专门的术后规划和护理.
- 强调一个多学科的方法的重要性,以解决肥胖在怀孕.
主要方法:
- 关于肥胖妇女怀孕结果研究的文献综述.
- 对肥胖患者的分娩诱导和剖腹产相关风险的分析.
- 综合当前的建议,并确定指导方针的差距.
主要成果:
- 肥胖的孕妇面临着更高的分娩诱导失败风险,需要结合方法.
- 肥胖女性的剖腹产带来了独特的外科手术和麻醉挑战.
- 产后并发症需要密切监测和专业护理.
结论:
- 多学科的方法对于优化肥胖孕妇的结果至关重要.
- 对于肥胖患者的剖腹产需要专门的指导方针.
- 对这个高危人群来说,全面的术前和产后护理是必不可少的.
相关概念视频
Obesity
505
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
505
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Enteral Nutrition I: Orogastric and Nasogastric Feeding
287
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
287
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
148
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
148
Insulin: Dosing Regimen and Adverse Effects
174
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
174
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285

